HomeMBCOF • OTCMKTS
add
Marvel Biosciences Corp
Previous close
$0.11
Day range
$0.11 - $0.11
Year range
$0.037 - $0.12
Market cap
8.06M CAD
Avg Volume
4.55K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 250.32K | 9.45% |
Net income | -257.41K | 16.24% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 389.02K | 78.70% |
Total assets | 500.51K | 44.13% |
Total liabilities | 3.43M | 10.36% |
Total equity | -2.93M | — |
Shares outstanding | 52.95M | — |
Price to book | -1.88 | — |
Return on assets | -173.93% | — |
Return on capital | 41.00% | — |
Cash Flow
Net change in cash
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Net income | -257.41K | 16.24% |
Cash from operations | -531.31K | -47.60% |
Cash from investing | — | — |
Cash from financing | 860.80K | — |
Net change in cash | 329.49K | 191.53% |
Free cash flow | -452.01K | -107.81% |
About
Founded
2021
Headquarters
Website
